These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8428005)

  • 41. [Diagnosis and treatment of heparin-induced thrombocytopenia (HIT) based on its atypical immunological features].
    Miyata S; Maeda T
    Rinsho Ketsueki; 2016 Mar; 57(3):322-32. PubMed ID: 27076245
    [TBL] [Abstract][Full Text] [Related]  

  • 42. On the role of platelet Fc gamma RIIa phenotype in heparin-induced thrombocytopenia.
    Brandt JT; Isenhart CE; Osborne JM; Ahmed A; Anderson CL
    Thromb Haemost; 1995 Dec; 74(6):1564-72. PubMed ID: 8772238
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heparin-induced thrombocytopenia in paediatric patients--a review of the literature and a new case treated with danaparoid sodium.
    Ranze O; Ranze P; Magnani HN; Greinacher A
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S130-3. PubMed ID: 10650852
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia.
    Legnani C; Cini M; Pili C; Boggian O; Frascaro M; Palareti G
    Thromb Haemost; 2010 Aug; 104(2):402-9. PubMed ID: 20539902
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Simultaneous binding of heparin and platelet factor-4 to platelets: further insights into the mechanism of heparin-induced thrombocytopenia.
    Horne MK; Hutchison KJ
    Am J Hematol; 1998 May; 58(1):24-30. PubMed ID: 9590145
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Perioperative use of iloprost in cardiac surgery patients diagnosed with heparin-induced thrombocytopenia-reactive antibodies or with true HIT (HIT-reactive antibodies plus thrombocytopenia): An 11-year experience.
    Palatianos G; Michalis A; Alivizatos P; Lacoumenda S; Geroulanos S; Karabinis A; Iliopoulou E; Soufla G; Kanthou C; Khoury M; Sfyrakis P; Stavridis G; Astras G; Vassili M; Antzaka C; Marathias K; Kriaras I; Tasouli A; Papadopoulos K; Katafygioti M; Matoula N; Angelidis A; Melissari E
    Am J Hematol; 2015 Jul; 90(7):608-17. PubMed ID: 25808486
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heparin and oversulfated heparin byproduct induce thrombin generation through contact system activation in plasma of patients with HIT.
    Yi Qian ; Jing Pan ; Xiaodong Zhou ; Weiser P; Hong Lu ; Shih FF; Porche-Sorbet R; Eby C; Lijuan Zhang
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):251-60. PubMed ID: 20460351
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Heparin-induced thrombocytopenia.
    Chong BH
    Aust N Z J Med; 1992 Apr; 22(2):145-52. PubMed ID: 1530537
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk factors for thrombosis in patients with immune mediated heparin-induced thrombocytopenia.
    Fabris F; Luzzatto G; Soini B; Ramon R; Scandellari R; Randi ML; Girolami A
    J Intern Med; 2002 Aug; 252(2):149-54. PubMed ID: 12190890
    [TBL] [Abstract][Full Text] [Related]  

  • 50. What is the potential for overdiagnosis of heparin-induced thrombocytopenia?
    Lo GK; Sigouin CS; Warkentin TE
    Am J Hematol; 2007 Dec; 82(12):1037-43. PubMed ID: 17722079
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk factors for heparin-induced thrombocytopenia: Focus on Fcγ receptors.
    Rollin J; Pouplard C; Gruel Y
    Thromb Haemost; 2016 Oct; 116(5):799-805. PubMed ID: 27358188
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Apixaban as an alternate oral anticoagulant for the management of patients with heparin-induced thrombocytopenia.
    Walenga JM; Prechel M; Hoppensteadt D; Escalante V; Chaudhry T; Jeske WP; Bakhos M
    Clin Appl Thromb Hemost; 2013 Sep; 19(5):482-7. PubMed ID: 23780399
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heparin-induced thrombocytopenia: association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis in platelet aggregation.
    Chong BH; Pitney WR; Castaldi PA
    Lancet; 1982 Dec; 2(8310):1246-9. PubMed ID: 6128550
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Platelet count recovery and seroreversion in immune HIT despite continuation of heparin: further observations and literature review.
    Shih AW; Sheppard JI; Warkentin TE
    Thromb Haemost; 2017 Oct; 117(10):1868-1874. PubMed ID: 28837208
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The relationship between the antiphospholipid syndrome and heparin-induced thrombocytopenia.
    Hoppensteadt DA; Walenga JM
    Hematol Oncol Clin North Am; 2008 Feb; 22(1):1-18, v. PubMed ID: 18207062
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evolving concepts of pathogenesis of heparin-induced thrombocytopenia: Diagnostic and therapeutic implications.
    Chong BH
    Int J Lab Hematol; 2020 Jun; 42 Suppl 1():25-32. PubMed ID: 32543064
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional heterogeneity of antiheparin-platelet factor 4 antibodies: implications in the pathogenesis of the HIT syndrome.
    Ahmad S; Walenga JM; Jeske WP; Cella G; Fareed J
    Clin Appl Thromb Hemost; 1999 Oct; 5 Suppl 1():S32-7. PubMed ID: 10726034
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of aspirin on heparin-induced thrombocytopenia (HIT) in a patient requiring hemodialysis.
    Matsuo T; Yamada T; Chikahira Y; Kadowaki S
    Blut; 1989 Oct; 59(4):393-5. PubMed ID: 2790222
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immune mechanisms in heparin-induced thrombocytopenia: no evidence for immunoglobulin M anti-idiotype antibodies.
    Selleng K; Warkentin TE; Sheppard JA; Greinacher A
    Transfusion; 2009 Sep; 49(9):1812-8. PubMed ID: 19497062
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly.
    Cines DB; Rauova L; Arepally G; Reilly MP; McKenzie SE; Sachais BS; Poncz M
    J Clin Apher; 2007 Feb; 22(1):31-6. PubMed ID: 17285619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.